ARL17A and supranuclear palsy, progressive, 1: ,34 We identified MAPT, CRHR1, KANSL1, ARL17A, and ARHGAP27 to be independently significant in multiple different omics for AD, PD, and PSP (Tables S3, S4, and S5).